New Salicylanilide Derivatives and Their Peptide Conjugates as Anticancer Compounds: Synthesis, Characterization, and In Vitro Effect on Glioblastoma

• Lilla Horváth,
• Beáta Biri-Kovács,
• Zsuzsa Baranyai,
• Bence Stipsicz,
• Előd Méhes,
• Bálint Jezsó,
• Martin Krátký,
• Jarmila Vinšová,
• Szilvia Bősze

Affiliations

Lilla Horváth

ELKH-ELTE Research Group of Peptide Chemistry, Eötvös Loránd Research Network, Eötvös Loránd University, Budapest, Hungary

Beáta Biri-Kovács

ELKH-ELTE Research Group of Peptide Chemistry, Eötvös Loránd Research Network, Eötvös Loránd University, Budapest, Hungary

Zsuzsa Baranyai

ELKH-ELTE Research Group of Peptide Chemistry, Eötvös Loránd Research Network, Eötvös Loránd University, Budapest, Hungary

Bence Stipsicz

ELKH-ELTE Research Group of Peptide Chemistry, Eötvös Loránd Research Network, Eötvös Loránd University, Budapest, Hungary

Előd Méhes

Institute of Physics, Department of Biological Physics, Eötvös Loránd University, Budapest, Hungary

Bálint Jezsó

Research Centre for Natural Sciences, Institute of Enzymology, Budapest, Hungary

Martin Krátký

Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic

Jarmila Vinšová

Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic

Szilvia Bősze

ELKH-ELTE Research Group of Peptide Chemistry, Eötvös Loránd Research Network, Eötvös Loránd University, Budapest, Hungary